Biotechnology
Romark Laboratories, L.C., a privately-owned biopharmaceutical company, today announced the completion of enrollment into its Phase II clinical trial to evaluate the safety and efficacy of nitazoxanide in combination with standard of care therapy in U.S.
02:03 May 21, 2008
Anesiva, Inc. today announced that the U.S. Food and Drug Administration has accepted the company's electronic supplemental New Drug Application filing to expand the indication for Zingo to treat pain associated with peripheral IV insertions and blood dr
02:03 May 21, 2008
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
23:33 May 20, 2008
Daiichi Sankyo Co., Ltd. announced today that it has entered into an agreement to acquire the privately held firm, U3 Pharma AG, a German biotechnology company focusing on research into antibodies for the treatment of cancer.
21:13 May 20, 2008
SkyePharma PLC announces Succession Plan
21:03 May 20, 2008
Today at the World Congress of Cardiology , the press conference entitled "New Perspectives in Atrial Fibrillation Management" chaired by John Camm, Professor of Clinical Cardiology,St George's University ofLondon, highlighted the importance of
20:13 May 20, 2008
Today at the World Congress of Cardiology , the press conference entitled "New Perspectives in Atrial Fibrillation Management" chaired by John Camm, Professor of Clinical Cardiology,St George's University ofLondon, highlighted the importance of
20:13 May 20, 2008
Sahajanand Medical Technologies Pvt. Ltd. , Surat,India, leading developer and manufacturer of drug-eluting stents, welcomed the positive results of the prospective, randomized nine months results of PAINT trial .
14:43 May 20, 2008
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced the presentation of data from a Phase 2b randomized, double-blind, placebo-controlled study assessing the safety and efficacy of linaclotide in patients with chronic constipatio
13:33 May 20, 2008
Ardea Biosciences, Inc. today announced that data was presented on the Company's lead mitogen-activated ERK kinase inhibitor, RDEA119, demonstrating potent activity in mouse models of colitis. An oral presentation of the data was given at Digestive Disea
13:33 May 20, 2008
Indevus Pharmaceuticals, Inc. today announced that data on NEBIDO , an investigational, long-acting intramuscular injection for the treatment of hypogonadism, was presented in a late breaker presentation at the 2008 American Urological Association Annual
11:23 May 20, 2008
eResearchTechnology, Inc. , , a leading provider of centralized electrocardiographic collection and interpretation services, announced today that Dr. Michael J. McKelvey, the Company's President and Chief Executive Officer, and Richard Baron, the Company
11:13 May 20, 2008
one with TELINTRA tablets in myelodysplastic syndrome, or MDS, and a second with TELINTRA tablets in cancer patients at risk for chemotherapy-induced neutropenia, or CIN.
11:13 May 20, 2008
Covalon Technologies Ltd. is pleased to announce that it has received approval from the Therapeutic Product Directorate at Health Canada to begin marketing the Corporation's proprietary products:
11:04 May 20, 2008
Stem Cell Therapeutics Corp. today announced its financial results for the period ended March 31, 2008.
11:04 May 20, 2008
43742 - 43756 of 48576 Stories
<<
<
Next 15 Biotechnology
>
>>
Search News
Daily News
